Phase 4Status unknown
Japanese Primary Prevention Project With Aspirin
Japanese Primary Prevention Project With Aspirin in the Elderly With One or More Risk Factors of Vascular Events: JPPP
- Sponsor
- Ministry of Health, Labour and Welfare, Japan (Government)
- Enrollment
- 10,000 planned
- Conditions
- Hypertension; Hyperlipidemia; Diabetes Mellitus
- Interventions
- Aspirin
- Ages
- adults, older adults
- Registry
- NCT00225849
Full record on ClinicalTrials.gov
From the registry
The purpose of this study is to investigate the balance between the risks and benefits of primary prevention by Aspirin in elderly Japanese patients with one or more cerebro/cardiovascular risk factors
Primary outcomes
- Composite event of cerebro/cardiovascular (CV) death, nonfatal cerebral stroke (of any cause) and nonfatal myocardial infarction (MI)
History
Study completion
Registered
Started
Papers citing this trial
- Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Elderly Japanese Patients with Atherosclerotic Risk Factors: Subanalysis of a Randomized Clinical Trial (JPPP-70)
American journal of cardiovascular drugs : drugs, devices, and other interventions
- Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial
JAMA